/NUTX
NUTX Stock - Nutex Health, Inc.
Healthcare|Medical - Healthcare Information ServicesNASDAQ
$171.93+3.05%
+$5.09 (+3.05%) • Dec 19
73
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.BUY
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.97
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).88
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.40
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+19.2%upside
Target: $204.94
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for NUTX
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$170.21 – $173.65
TARGET (TP)$205.00
STOP LOSS$158.18
RISK/REWARD1:2.4
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta2.01
52W High$193.00
52W Low$28.12
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $479.95M | $247.65M | $219.29M | $331.53M | $274.03M |
| Gross Profit | $196.26M | $34.77M | $15.42M | $179.28M | $157.61M |
| Gross Margin | 40.9% | 14.0% | 7.0% | 54.1% | 57.5% |
| Operating Income | $130.62M | $-31,773,748 | $-406,599,154 | $170.26M | $153.17M |
| Net Income | $52.18M | $-45,786,614 | $-424,780,446 | $132.59M | $105.97M |
| Net Margin | 10.9% | -18.5% | -193.7% | 40.0% | 38.7% |
| EPS | $10.23 | $-10.39 | $-100.50 | $33.55 | $24.69 |
Company Overview
Nutex Health, Inc. operates as a technology-enabled healthcare services company. It operates through two divisions: Hospital division and Population Health Management division. The Hospital division implements and operates health care models, including micro-hospitals, specialty hospitals, and hospital outpatient departments. This division owns and operates 21 facilities in 8 states. The Population Health Management division owns and operates provider networks, such as independent physician associations. Its management services organizations provide management, administrative, and other support services to its affiliated hospitals and physician groups. This division's cloud-based proprietary technology platform aggregates data across multiple information systems, settings, and sources to create a holistic view of each patient and provider, as well as allows to deliver care. The company is based in Houston, Texas.
Visit WebsiteRating Distribution
Strong Buy
0%
Buy / Outperform
3
100%
Hold / Neutral
0%
Sell / Underperform
0%
Analyst Consensus🟢 Bullish
3 Bullish0 Neutral/Bearish
Price Targets
$33
Average Target
↓ 81.0% Downside
Now
$3
Low
$33
Average
$50
High
Based on 3 analysts
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| November 12th 2024 | Maxim Group | Reiterated | Buy | $50← $45 |
| September 18th 2024 | Maxim Group | Initiation | Buy | $45 |
| February 22nd 2023 | Northland Capital | Initiation | Outperform | $3 |
Earnings History & Surprises
NUTXBeat Rate
60%
Last 10 quarters
Avg Surprise
+1235.0%
EPS vs Estimate
Beats / Misses
6/1
3 met exactly
Latest EPS
$7.76
Q4 2025
EPS Surprise History
Q1 24
No data
Q2 24
No data
Q3 24
+75.9%
$-0.07vs$-0.29
Q4 24
-616.7%
$-1.72vs$-0.24
Q1 25
+12455.6%
$11.12vs$-0.09
Q2 25
+11.8%
$2.56vs$2.29
Q4 25
+44.3%
$-3.02vs$-5.43
Q4 25
+328.7%
$7.76vs$1.81
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 11, 2026 | — | — | — | — |
Q4 2025 | Nov 19, 2025 | $1.81 | $7.76 | +328.7% | ✓ BEAT |
Q4 2025 | Nov 3, 2025 | $-5.43 | $-3.02 | +44.3% | ✓ BEAT |
Q2 2025 | May 13, 2025 | $2.29 | $2.56 | +11.8% | ✓ BEAT |
Q1 2025 | Mar 31, 2025 | $-0.09 | $11.12 | +12455.6% | ✓ BEAT |
Q4 2024 | Nov 8, 2024 | $-0.24 | $-1.72 | -616.7% | ✗ MISS |
Q3 2024 | Aug 8, 2024 | $-0.29 | $-0.07 | +75.9% | ✓ BEAT |
Q2 2024 | May 8, 2024 | — | $-0.10 | — | — |
Q1 2024 | Mar 28, 2024 | — | $-7.50 | — | — |
Q4 2023 | Nov 9, 2023 | $-1.50 | $-1.50 | 0.0% | = MET |
Q3 2023 | Aug 9, 2023 | $-1.50 | $-1.50 | 0.0% | = MET |
Q2 2023 | May 15, 2023 | $-3.00 | $-1.50 | +50.0% | ✓ BEAT |
Q1 2023 | Mar 2, 2023 | $-3.00 | $-3.00 | 0.0% | = MET |
Q4 2022 | Nov 21, 2022 | — | $-3.00 | — | — |
Q3 2022 | Aug 22, 2022 | — | $-4.50 | — | — |
Q2 2022 | May 13, 2022 | — | $-4.19 | — | — |
Q2 2022 | Apr 1, 2022 | — | $3.81 | — | — |
Q4 2021 | Nov 15, 2021 | — | $13.61 | — | — |
Q3 2021 | Aug 16, 2021 | — | $6.85 | — | — |
Q2 2021 | May 24, 2021 | — | $-1.12 | — | — |
Latest News
Nutex Health shares are trading higher after the company announced it extended its $25 million stock buyback.
📈 PositiveBenzinga•Dec 4, 2025, 04:16 PM
Nutex Health Extends $25M Stock Buyback Program By Over Six Months, Now Extended to March 31, 2026
📈 PositiveBenzinga•Dec 4, 2025, 10:37 AM
Nutex Health Addresses Short-Seller Report From Capybara Research, Noting That The Entity Appears Not To Exist And That Prior Lawsuits Against It Were Unserviceable Due To Efforts To Conceal The Identities And Locations Of Those Controlling It
➖ NeutralBenzinga•Nov 26, 2025, 09:12 PM
Nutex Health Reopens Red River ER & Hospital in Sherman, Texas
📈 PositiveBenzinga•Nov 24, 2025, 09:40 PM
Nutex Health shares are trading higher after the company reported better-than-expected Q3 financial results.
📈 PositiveBenzinga•Nov 20, 2025, 02:13 PM
Nutex Health Q3 EPS $7.76 Beats $1.09 Estimate, Sales $267.804M Beat $213.812M Estimate
📈 PositiveBenzinga•Nov 19, 2025, 09:34 PM
Nutex Health Q2 EPS $(2.95) Misses $1.09 Estimate, Sales $243.985M Beat $213.812M Estimate
➖ NeutralBenzinga•Nov 19, 2025, 09:20 PM
Nutex Health Posts 259% Surge In Cash Collections, 11% Jump In Patient Volume In Q3, Working To Regain Nasdaq Compliance
📈 PositiveBenzinga•Oct 20, 2025, 09:44 AM
Nutex Health Appoints Wesley Bamburg As COO, Effective October 13, 2025
➖ NeutralBenzinga•Sep 22, 2025, 10:34 AM
Derivative Lawsuit Filed Against Nutex Health Executives And Board Alleging Mismanagement, Fiduciary Breaches, And Securities Violations
📉 NegativeBenzinga•Sep 10, 2025, 08:27 PM
Nutex Health shares are trading lower after Maxim Group cut its price target on the stock from $225 to $205
📉 NegativeBenzinga•Aug 26, 2025, 04:09 PM
Maxim Group Maintains Buy on Nutex Health, Lowers Price Target to $205
➖ NeutralBenzinga•Aug 26, 2025, 03:57 PM
Nutex Health Faces Securities Class Action Lawsuit Filed August 22, 2025, Alleging Violations Tied To Short Seller Report
📉 NegativeBenzinga•Aug 25, 2025, 08:01 PM
Nutex Health shares are trading higher after the company reported a year-over-year increase for preliminary Q2 financial results.
📈 PositiveBenzinga•Aug 21, 2025, 02:16 PM
Reported Earlier, Nutex Health Preliminary Q2 Revenue $244M Up From $76.1M YoY, Adjusted EBITDA $71.6M Up From $6.8M YoY
📈 PositiveBenzinga•Aug 21, 2025, 07:31 AM
Reported Earlier, Nutex Health Discloses Non-Reliance On Previously Issued Financial Statements And Plans To Amend 2024 Form 10-K And First Quarter 2025 Form 10-Q
📉 NegativeBenzinga•Aug 21, 2025, 07:28 AM
Nutex Health down on delayed Q2 financial statements
📉 NegativeSeeking Alpha•Aug 15, 2025, 06:28 PM
Frequently Asked Questions about NUTX
What is NUTX's current stock price?
Nutex Health, Inc. (NUTX) is currently trading at $171.93 per share. The stock has moved +3.05% today.
What is the analyst price target for NUTX?
The average analyst price target for NUTX is $205.00, based on 1 analyst.
What sector is Nutex Health, Inc. in?
Nutex Health, Inc. operates in the Healthcare sector, specifically within the Medical - Healthcare Information Services industry. The company is traded on the NASDAQ exchange.
What is NUTX's market cap?
Nutex Health, Inc. has a market capitalization of $1.02 billion, making it a small-cap company.
Does NUTX pay dividends?
No, Nutex Health, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorAMN
AMN Healthcare Services, Inc.
$16.04
Mkt Cap: $0.6B
BFLY
Butterfly Network, Inc.
$3.56
Mkt Cap: $0.9B
CDNA
CareDx, Inc
$19.45
Mkt Cap: $1.0B
DAWN
Day One Biopharmaceuticals, Inc.
$9.24
Mkt Cap: $0.9B
DNA
Ginkgo Bioworks Holdings, Inc.
$8.10
Mkt Cap: $0.4B
EVH
Evolent Health, Inc.
$3.99
Mkt Cap: $0.5B
HSTM
HealthStream, Inc.
$23.94
Mkt Cap: $0.7B
MYGN
Myriad Genetics, Inc.
$6.55
Mkt Cap: $0.6B
PACB
Pacific Biosciences of California, Inc.
$1.84
Mkt Cap: $0.6B
REPL
Replimune Group, Inc.
$9.88
Mkt Cap: $0.8B
Explore stocks similar to NUTX for comparison